SLU-PP-332
ERRα Agonist — Exercise Mimetic
SLU-PP-332 is a small molecule agonist of estrogen-related receptor alpha (ERRα) — a transcription factor that governs the expression of genes controlling mitochondrial biogenesis, fatty acid oxidation, and oxidative metabolism in muscle. It has attracted attention as one of the most promising 'exercise mimetic' candidates in preclinical research.
At a Glance
ERRα is often called the 'exercise transcription factor' because it is the primary regulator of gene networks activated during sustained aerobic exercise — including PGC-1α co-activation, mitochondrial biogenesis, and the metabolic shift toward fat oxidation that defines endurance fitness.
Preclinical data from Washington University has shown that SLU-PP-332 can activate these same gene networks pharmacologically — producing measurable improvements in endurance performance and metabolic markers in sedentary mice without exercise.
Unlike AMPK activators (metformin, MOTS-c) or PPAR agonists (GW501516), ERRa sits upstream in the same pathway exercise naturally activates, potentially producing a more complete mimicry of exercise-induced metabolic adaptation.
This compound operates through several converging biological pathways, which helps explain the breadth of effects observed across different tissue and metabolic models.
ERRα Transcription Factor Agonism
Directly activates estrogen-related receptor alpha — the master transcription factor governing oxidative metabolism gene networks in skeletal muscle.
Mitochondrial Biogenesis
Upregulates PGC-1α, TFAM, and downstream mitochondrial biogenesis genes — increasing mitochondrial density in muscle analogous to endurance training adaptation.
Fat Oxidation Enhancement
Activates fatty acid oxidation gene networks, shifting muscle metabolism toward fat as primary fuel — the metabolic hallmark of aerobic fitness.
Endurance Performance
Preclinical data shows improved running endurance in sedentary mice — physical performance improvement via metabolic rather than structural means.
Preclinical and clinical models have investigated this compound across a wide range of physiological contexts and tissue types.
- Exercise mimetic research — ERRα activation as surrogate for aerobic training adaptation
- Mitochondrial biogenesis — PGC-1α pathway activation studies
- Endurance performance — treadmill and VO2max studies in preclinical models
- Fat oxidation — metabolic fuel substrate shift from glucose to fat
- Muscle metabolic flexibility — adaptation to varying energy substrates
- Heart failure research — cardiac muscle mitochondrial density restoration
- Comparison with AMPK activators — upstream vs downstream exercise pathway activation
SLU-PP-332 represents the most upstream pharmacological approach to exercise mimicry — targeting the transcription factor that orchestrates the adaptive response rather than individual downstream effects.
SLU-PP-332, MOTS-c, and GW501516 represent three different pharmacological approaches to exercise mimicry — each activating different nodes in the metabolic adaptation pathway.
| Aspect | SLU-PP-332 | MOTS-c | GW501516 (ref) |
|---|---|---|---|
| Target | ERRα (transcription factor) | AMPK (kinase) | PPARδ (nuclear receptor) |
| Pathway | Upstream transcriptional | Midstream metabolic signaling | Transcriptional (different pathway) |
| Mitochondrial Biogenesis | Direct via PGC-1α | Indirect via AMPK | Via PPARdb-PGC1α |
| Evidence Level | Early preclinical | Preclinical + emerging clinical | Preclinical (concerns halted) |
| Exercise Mimicry | High — ERRa is exercise TF | Partial — AMPK only | Partial — endurance genes |
The following reflects findings from published preclinical and clinical safety assessments where available.
Most upstream exercise pathway target — ERRa is the primary transcription factor exercise activates
Oral bioavailability in preclinical models
Clean mechanistic rationale — the ERRa pathway is well-characterized in exercise physiology
Very early stage — compelling preclinical data but human studies not yet initiated; long-term safety profile unknown
This overview is strictly educational and based on publicly available scientific literature as of 2026. It does not constitute medical advice. All Helixera Labs products are for laboratory research use only. Not for human or veterinary use. · Helixera Labs LLC © 2026